06:01 PM EDT, 07/01/2024 (MT Newswires) -- Traws Pharma ( TRAW ) filed a registration statement Monday for the potential sale of 128.9 million common shares by certain selling stockholders from time to time.

The filing also covers shares issued by the company related to a merger agreement with Trawsfynydd Therapeutics.

Traws Pharma ( TRAW ) shares rose 6.7% higher in recent after-hours activity.

Price: 0.4600, Change: +0.03, Percent Change: +6.73